Incyte Biosciences Canada today announced that Health Canada has approved Opzelura® (ruxolitinib (as ruxolitinib phosphate)) ...
Ericsson today announced the signing of a USD $3 billion partnership agreement with Export Development Canada (EDC) to expand investment in Canadian research and development, deepen domestic supply ...
Every time Adam publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from Business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results